S6 pS240 Antibody, anti-human, REAfinity™
Synonyms: RPS6, NP33, RS6
RECOMBINANT EXTENDED VALIDATION
Bioz Star90/100 Bioz rating
5 Citations
Clone:
REA420 | N4-41
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for S6 pS240 Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
Vio B515
Description:
Human peripheral blood mononuclear cells (PBMCs), either left unstimulated (left peak) or stimulated with 50 nM Phorbol 12-myristate 13-acetate (PMA) for 30 minutes at 37 °C, were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were stained with Anti-S6 pS240 antibodies and analyzed by flow cytometry using the MACSQuant® Analyzer. CD14– cells were pregated for the analysis. Cell debris were excluded from the analysis based on scatter signals.
Intracellular flow cytometry applications
APC
FITC
PE
Vio B515
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-117-521, 130-117-372
Description:
Human peripheral blood mononuclear cells (PBMCs), either left unstimulated (left peak) or stimulated with 50 nM Phorbol 12-myristate 13-acetate (PMA) for 30 minutes at 37 °C, were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were stained with Anti-S6 pS240 antibodies and analyzed by flow cytometry using the MACSQuant® Analyzer. CD14– cells were pregated for the analysis. Cell debris were excluded from the analysis based on scatter signals.

Application image
Extended validation for S6 pS240 Antibody, anti-human, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA420
N4-41
high

Cells were incubated with an excess of purified unconjugated S6 pS240 (REA420) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for S6 pS240. Human peripheral blood mononuclear cells (PBMCs) were stimulated with 200ng/ml Phorol-12-myristat-13-acetat (PMA) for 30min at 37°C. Cells were fixed and permeabiliz using the Cell Signaling Buffer Set A and stained with S6 pS240 antibodies and plotted against the side scatter. As a control, S6 pS240 antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.

Specifications for S6 pS240 Antibody, anti-human, REAfinity™
Overview

Clone REA420 recognizes the human 40S ribosomal protein S6 antigen phosphorylated at serine 240 (pS240). Ribosomal protein S6 is one of 33 proteins that comprise the 40 S ribosomal subunit and becomes phosphorylated at several serine residues upon mitogen stimulation. It plays an important role in controlling cell growth and proliferation through the selective translation of particular classes of mRNA. Activation of the p90 ribosomal S6 kinases (RSKs) by serum, growth factors, tumor promoting phorbol esters, and oncogenic Ras is required for ribosomal protein S6 phosphorylation downstream of the Ras/ERK signaling cascade. The phosphorylation sites in ribosomal protein S6 have been mapped to five clustered serine residues – S235, S236, S240, S244, and S247 – which are located at the C terminus and are conserved from Drosophila to mammals.

Additional information: Clone REA420 displays negligible binding to Fc receptors.

Alternative names

RPS6, NP33, RS6

Detailed product information

Technical specifications

Clone
REA420
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
S6 pS240
Molecular mass of antigen [kDa]
29
Entrez Gene ID
RRID
AB_2928828, AB_2928827, AB_2653390, AB_2653391, AB_2653392, AB_2653393, AB_2857419, AB_2857418

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for S6 pS240 Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support